Signal
Thyme Care, which focuses on filling cancer treatment gaps via a virtual navigation platform, raised a $125M Series E at a $2B+ valuation, up from $1B+ in 2025
First reported by CNBC ·
The signal
●●●○
Compiled by AI from CNBC and Techmeme
What happened
Despite recent advancements in oncology, the branch of medicine focused on the study, prevention, diagnosis and treatment of cancer...
AI-written summary. May contain errors.
Funding
Related
-
Z.ai says it plans to raise $5B+ via equity and debt to fund its AI investments, including ~$2B through a share placement, after raising $4B in July
wsj.com · 1h ago · ●●●○
-
Sources: Australian data center provider Firmus is seeking to raise up to $5B in an IPO at the end of October, in one of the largest-ever IPOs in Australia
bloomberg.com · 2h ago · ●●●○
-
Filing: San Jose-based Chinese optical module maker Ligent seeks ~$727M in a Hong Kong IPO, after its rival Zhongji Innolight's $6.8B Hong Kong debut in July
-
Source: Anthropic has selected the Nasdaq for its potential IPO
businessinsider.com · 19h ago · ●●○○
-
Source: Anthropic has selected the Nasdaq for its potential IPO, following SpaceX's record Nasdaq debut in June, as the AI lab targets an October listing